Follow
Nicolas Palaskas
Nicolas Palaskas
Verified email at mdanderson.org
Title
Cited by
Cited by
Year
Immune checkpoint inhibitor myocarditis: pathophysiological characteristics, diagnosis, and treatment
N Palaskas, J Lopez‐Mattei, JB Durand, C Iliescu, A Deswal
Journal of the American Heart Association 9 (2), e013757, 2020
3312020
The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity: JACC: CardioOncology Primer
L Zhang, KL Reynolds, AR Lyon, N Palaskas, TG Neilan
Cardio Oncology 3 (1), 35-47, 2021
1042021
Incidence and onset of severe cardiac events after radiotherapy for esophageal cancer
X Wang, NL Palaskas, SW Yusuf, J Abe, J Lopez-Mattei, J Banchs, ...
Journal of Thoracic Oncology 15 (10), 1682-1690, 2020
822020
Evaluation and management of cardiac tumors
N Palaskas, K Thompson, G Gladish, AM Agha, S Hassan, C Iliescu, ...
Current treatment options in cardiovascular medicine 20, 1-14, 2018
802018
Clinical strategy for the diagnosis and treatment of immune checkpoint inhibitor–associated myocarditis: a narrative review
LH Lehmann, J Cautela, N Palaskas, AH Baik, WC Meijers, Y Allenbach, ...
JAMA cardiology 6 (11), 1329-1337, 2021
782021
Inflammatory myositis in cancer patients receiving immune checkpoint inhibitors
J Aldrich, X Pundole, S Tummala, N Palaskas, CR Andersen, M Shoukier, ...
Arthritis & Rheumatology 73 (5), 866-874, 2021
752021
Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy
NL Palaskas, A Segura, L Lelenwa, BA Siddiqui, SK Subudhi, ...
European Journal of Heart Failure 23 (10), 1725-1735, 2021
612021
An update on gender disparities in coronary heart disease care
T Shah, N Palaskas, A Ahmed
Current atherosclerosis reports 18, 1-8, 2016
612016
Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis
AM Agha, P Parwani, A Guha, JB Durand, CA Iliescu, S Hassan, ...
Open heart 5 (2), e000881, 2018
582018
Electrocardiographic manifestations of immune checkpoint inhibitor myocarditis
JR Power, J Alexandre, A Choudhary, B Ozbay, S Hayek, A Asnani, ...
Circulation 144 (18), 1521-1523, 2021
562021
Targeted cancer therapies with pericardial effusions requiring pericardiocentesis focusing on immune checkpoint inhibitors
N Palaskas, J Morgan, T Daigle, J Banchs, JB Durand, D Hong, A Naing, ...
The American Journal of Cardiology 123 (8), 1351-1357, 2019
482019
Safety of diagnostic and therapeutic cardiac catheterization in cancer patients with acute coronary syndrome and chronic thrombocytopenia
C Iliescu, DV Balanescu, T Donisan, DE Giza, EDM Gonzalez, ...
The American Journal of Cardiology 122 (9), 1465-1470, 2018
482018
Chemotherapeutic agents and the risk of ischemia and arterial thrombosis
SA Hassan, N Palaskas, P Kim, C Iliescu, J Lopez-Mattei, E Mouhayar, ...
Current atherosclerosis reports 20, 1-9, 2018
452018
Modern radiotherapy and risk of cardiotoxicity
E Koutroumpakis, NL Palaskas, SH Lin, J Abe, Z Liao, J Banchs, ...
Chemotherapy 65 (3-4), 65-76, 2020
442020
Immunomodulatory treatment of immune checkpoint inhibitor-induced myocarditis: Pathway toward precision-based therapy
DV Balanescu, T Donisan, N Palaskas, J Lopez-Mattei, PY Kim, LM Buja, ...
Cardiovascular Pathology 47, 107211, 2020
422020
Cardiovascular manifestations of Erdheim–Chester disease
AS Ghotra, K Thompson, J Lopez‐Mattei, D Bawa, R Hernandez, ...
Echocardiography 36 (2), 229-236, 2019
312019
Multimodality imaging in carcinoid heart disease
AM Agha, J Lopez-Mattei, T Donisan, D Balanescu, CA Iliescu, J Banchs, ...
Open heart 6 (1), e001060, 2019
292019
Cardiomuscular biomarkers in the diagnosis and prognostication of immune checkpoint inhibitor myocarditis
LH Lehmann, MB Heckmann, G Bailly, D Finke, A Procureur, JR Power, ...
Circulation 148 (6), 473-486, 2023
232023
Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphoma
RE Steiner, J Banchs, E Koutroumpakis, M Becnel, C Gutierrez, P Strati, ...
Haematologica 107 (7), 1555, 2022
232022
Machine learning-augmented propensity score analysis of percutaneous coronary intervention in over 30 million cancer and non-cancer patients
DJ Monlezun, S Lawless, N Palaskas, S Peerbhai, K Charitakis, ...
Frontiers in cardiovascular medicine 8, 620857, 2021
232021
The system can't perform the operation now. Try again later.
Articles 1–20